Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Aldevron
Sort By
Newest First
1 / 1
1 / 1
Partnership
Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline
Aldevron
PR-M05-21-018
May 28, 2021
CRISPR RNPs
CRISPR RNPs and the Future of Cell and Gene Therapy
Thomas Lynch, Ph.D.
Aldevron
PAP-Q3-20-CL-002
Sep 29, 2020
Collaboration
Dragonfly Therapeutics and Bristol Myers Squibb Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program
Bristol-Myers Squibb
PR-M08-20-NI-35
Aug 20, 2020
Plasmids
The Pivotal Role of Plasmid DNA
Robert Reames
Aldevron
PAP-Q4-19-CL-006
Dec 06, 2019
Expansion
Aldevron Breaks Ground on 14-Acre Campus Expansion
Aldevron
PR-M08-19-NI-059
Aug 20, 2019
Gene Therapy
Expanding GMP Gene Therapy Manufacturing Capacity
Aldevron
PTV-M08-19-BIO-003
Aug 12, 2019
Gene Therapy
Accelerating Innovation for Gene Therapy
Aldevron
PTV-M08-19-BIO-002
Aug 12, 2019
M&A
EQT to Acquire Majority Interest in Aldevron – the Leading Global Supplier of Plasmid DNA Used in Cell and Gene Therapies
Aldevron
PR-M07-19-NI-081
Jul 31, 2019
Cell and Gene Therapy
Gene Editing Solutions with Off-the-Shelf GMP CRISPR/Cas9 Nucleases
Thomas G. Foti
Aldevron
PAO-06-2019-CL-002
Jun 11, 2019
Cell and Gene Therapy
Aldevron to Build 14-Acre Gene Therapy Manufacturing Campus
Aldevron
PR-M06-NI-002
Jun 03, 2019
AAV and LV Vectors
Supporting AAV and Lentiviral Vector Development and Commercialization
James Brown, Ph.D.
Aldevron
PAP-Q2-2019-CL-005
May 24, 2019
